Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19
- PMID: 34059386
- PMCID: PMC8141265
- DOI: 10.1016/j.ajem.2021.05.053
Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19
Conflict of interest statement
Declaration of Competing Interest I have no funding and no conflict of interest.
Comment on
-
Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination.Am J Emerg Med. 2021 Nov;49:441.e3-441.e4. doi: 10.1016/j.ajem.2021.05.001. Epub 2021 May 4. Am J Emerg Med. 2021. PMID: 33980419 Free PMC article.
References
-
- Pai M., Chan B., Stall N.M., et al. Vaccine-induced immune thrombotic thrombocytopenia(VITT) following adenovirus vector COVID-19 vaccination. Sci Br. 2021;2(17) doi: 10.47326/ocsat.2021.02.17.2.0. https://covid19-sciencetable.ca/science-briefs - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
